Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion

Background: Faster aspart is insulin aspart (IAsp) in a new formulation, which in continuous subcutaneous insulin infusion (CSII) in subjects with type 1 diabetes has shown a faster onset and offset of glucose-lowering effect than IAsp. Methods: This double-blind, randomized, crossover active-contro...

Descripción completa

Detalles Bibliográficos
Autores principales: Bode, Bruce W., Johnson, Joseph A., Hyveled, Liselotte, Tamer, Søren C., Demissie, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248540/
https://www.ncbi.nlm.nih.gov/pubmed/28055230
http://dx.doi.org/10.1089/dia.2016.0350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248540/
https://www.ncbi.nlm.nih.gov/pubmed/28055230
http://dx.doi.org/10.1089/dia.2016.0350

Ejemplares similares